Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vir Biotechnology Inc (NQ: VIR ) 8.600 -0.050 (-0.58%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 6, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Vir Biotechnology Inc < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > Vir Biotechnology to Participate in the 44th Annual Goldman Sachs Global Healthcare Conference June 05, 2023 From Vir Biotechnology, Inc. Via GlobeNewswire WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake May 19, 2023 An advisory group for the World Health Organization said the current crop of shots should be updated to target the currently dominant XBB strains for the Via Benzinga Vir Biotechnology to Host a Virtual-Only 2023 Annual Meeting of Stockholders May 17, 2023 From Vir Biotechnology, Inc. Via GlobeNewswire Vir Biotechnology Appoints Jeff Calcagno, M.D., as Executive Vice President and Chief Business Officer May 15, 2023 From Vir Biotechnology, Inc. Via GlobeNewswire What 8 Analyst Ratings Have To Say About Vir Biotechnology April 04, 2023 Via Benzinga Where Vir Biotechnology Stands With Analysts February 24, 2023 Via Benzinga Vir Biotechnology Announces First Patient Dosed in New Phase 2 Chronic Hepatitis B Virus Trial Evaluating Combinations of VIR-2218, VIR-3434, PEG-IFNα and an NRTI May 11, 2023 From Vir Biotechnology, Inc. Via GlobeNewswire 7 Top-Rated Stocks That Will Boost Your Portfolio in 2023 May 10, 2023 For those seeking to rise above the muck in a big way, these top-rated stocks to buy might accomplish just that. Via InvestorPlace WHO Ends Global Emergency Status for COVID-19 3 Years After Declaration, CDC Director Resigns May 08, 2023 The World Health Organization ended the global emergency Via Benzinga The 7 Best Bargain Stocks to Buy for May 2023 May 04, 2023 With inflation crimping everyone’s wallet, these best bargain stocks to buy can make your dollars stretch significantly. Via InvestorPlace Vir Biotechnology's Earnings Outlook February 22, 2023 Via Benzinga Vir Biotechnology Provides Corporate Update and Reports First Quarter 2023 Financial Results May 04, 2023 From Vir Biotechnology, Inc. Via GlobeNewswire Vir Biotechnology to Participate in the BofA Securities 2023 Health Care Conference May 03, 2023 From Vir Biotechnology, Inc. Via GlobeNewswire Vir Biotechnology Receives Expanded Support to Develop Its Novel T Cell Vaccine Platform with New $10 Million Grant for HIV Prevention May 02, 2023 From Vir Biotechnology, Inc. Via GlobeNewswire Why Shares of Keros Therapeutics Jumped This Week April 21, 2023 The company appointed a new director and an analyst reiterated his position on the stock. Via The Motley Fool Vir Biotechnology to Participate in the 22nd Annual Needham Virtual Healthcare Conference April 11, 2023 From Vir Biotechnology, Inc. Via GlobeNewswire Biden Administration Launches $5B Program To Boost Development Of Pan-Coronavirus Vaccine, Treatments April 11, 2023 The White House plans to devote $5 billion to develop effective treatments and vaccines against current and future Covid variants, a Department of Health and Human Services (HHS) spokesperson and a... Via Benzinga 7 Thrilling Biotech Stocks for Aggressive Investors to Buy April 05, 2023 Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own. Via InvestorPlace Where Did COVID-19 Really Originate? Biden Signs Bill To Declassify Origins Information March 21, 2023 Via Benzinga Biotech Stocks And The SVB Collapse — Here's What We Know March 14, 2023 The collapse of SVB will have a big impact on early-stage, venture-backed companies. Via Investor's Business Daily Vir Biotechnology to Participate in the Barclays Global Healthcare Conference March 08, 2023 From Vir Biotechnology, Inc. Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For March 6, 2023 March 06, 2023 Via Benzinga Vir Biotechnology Gets Price Targets Cuts By Analysts After Q4 Results March 06, 2023 Vir Biotechnology, Inc. (NASDAQ: VIR) reported worse-than-expected Q4 results. Vir Biotechnology posted a Q4 loss of $0.76 per share, versus market expectations of $0.39 per share. The company’s... Via Benzinga The Top 7 Growth Stocks in Biotech March 03, 2023 The biotech sector always houses a great selection of growth stocks that can grow rapidly and reward investors over the long-term. Via InvestorPlace Vir Biotechnology to Participate in the Cowen 43rd Annual Health Care Conference February 28, 2023 From Vir Biotechnology, Inc. Via GlobeNewswire Coronavirus Vaccine Market To Surpass $95 Billion By 2028 February 28, 2023 EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NASDAQ:NVAX),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END Via FinancialNewsMedia Exposures COVID-19 12 Health Care Stocks Moving In Thursday's After-Market Session February 23, 2023 Via Benzinga Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results February 23, 2023 From Vir Biotechnology, Inc. Via GlobeNewswire NVIDIA To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Thursday February 23, 2023 Goldman Sachs boosted the price target for Vir Biotechnology, Inc. (NASDAQ: VIR) from $41 to $53. Goldman Sachs analyst Paul Choi maintained a Buy rating on the stock. Vir Biotechnology shares rose... Via Benzinga Earnings Scheduled For February 23, 2023 February 23, 2023 Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.